SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Analysis Sans Fronti??res
16 references·1 citing·36 second hop
Analysis Sans Fronti??res (2006)Analysis Sans Fronti??resWhither trial‐based economic evaluation for health care decision making? (2006)Whither trial‐based economic …Using Value of Information Analysis to Prioritise Health Research (2006)Using Value of Information An…Methods for the economic evaluation of health care programmes, 3rd ed (2006)Methods for the economic eval…Decision Modelling For Health Economic Evaluation (2006)Decision Modelling For Health…Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis (2006)Bayesian Methods for Evidence…Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra (2005)Probabilistic sensitivity ana…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence? (2005)Establishing the Cost-Effecti…National Institute for Clinical Excellence and its value judgments (2004)National Institute for Clinic…Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Generalisability in economic …Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Cost‐effectiveness acceptabil…NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE) (2002)NATIONAL INSTITUTE FOR CLINIC…A rational framework for decision making by the National Institute For Clinical Excellence (NICE) (2002)A rational framework for deci…Health Economic Guidelines—Similarities, Differences and Some Implications (2001)Health Economic Guidelines—Si…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)The irrelevance of inference:…Estimating country-specific cost-effectiveness from multinational clinical trials (1998)Estimating country-specific c…A systematic review of pharmacoeconomic guidelines (2017)A systematic review of pharma…Cost-Effectiveness in Health and Medicine (1996)Methods for Meta-Analysis in Medical Research (2000)Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies (2005)Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias (2009)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)Meta-analysis in clinical trials (1986)Empirical Evidence of Bias (1995)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Economic Evaluation for Devices and Drugs—Same or Different? (2008)Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI) (2008)Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Regret Theory: An Alternative Theory of Rational Choice Under Uncertainty (1982)Net Health Benefits (1998)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)EuroQol: the current state of play (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)Delivering affordable cancer care in high-income countries (2011)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)A guide to cost-effectiveness acceptability curves (2005)Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting (2011)Markov Models in Medical Decision Making (1993)An Introduction to Markov Modelling for Economic Evaluation (1998)Expected Value of Sample Information Calculations in Medical Decision Modeling (2004)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Model Parameter Estimation and Uncertainty Analysis (2012)Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 2006Decision Modelling For Health Economic Evaluation3,144 cited
  • 2006Methods for the economic evaluation of health care programmes, 3rd ed956 cited
  • 2004Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions945 cited
  • 1999The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies891 cited
  • 2004National Institute for Clinical Excellence and its value judgments767 cited
  • 2005Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra472 cited
  • 2002A rational framework for decision making by the National Institute For Clinical Excellence (NICE)455 cited
  • 2004Generalisability in economic evaluation studies in healthcare: a review and case studies441 cited
  • 2006Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis420 cited
  • 2002NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE)411 cited
  • 2006Whither trial‐based economic evaluation for health care decision making?407 cited
  • 2001Health Economic Guidelines—Similarities, Differences and Some Implications322 cited
  • 2006Using Value of Information Analysis to Prioritise Health Research279 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 1998Estimating country-specific cost-effectiveness from multinational clinical trials125 cited
  • 2005Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?121 cited
  • Cited by

    • 2017A systematic review of pharmacoeconomic guidelines56 cited